Ranbaxy’s anti-malaria drug Synriam wins Innovation Award

(From L-R): Dr Nilanjan Saha, Vice President – Medical, Global Marketing, Ranbaxy and Umang Chaturvedi, Global Head, Corporate Affairs, Ranbaxy receiving the award from S Jaipal Reddy, Minister for Science & Technology and Earth Sciences.

Ranbaxy Laboratories has been conferred with the Innovation Excellence Platinum Award at the ASSOCHAM Innovation Awards 2013 in the science and technology category for its new anti-malaria drug, Synriam. The award was given by Jaipal Reddy, Minister for Science & Technology and Earth Sciences.

India’s First New Drug, Synriam, was launched by Ranbaxy last year on April 25th (World Malaria Day). The drug is used for the treatment of plasmodium falciparum malaria, in adults. Ranbaxy is working to make this new treatment available in African, Asian and South American markets where malaria is rampant. The company plans to submit New Drug Applications for market authorisation of Synriam in various African countries in 2013. The company also has plans to extend the benefits of Synriam to children in the malaria endemic zones of Asia and Africa.

Last year, Synriam won the Golden Peacock Innovative Product/ Service Award.

EP News Bureau – Mumbai